Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function

D Martins-de-Souza, PC Guest, N Vanattou-Saifoudine, H Rahmoune, Sabine Bahn

Research output: Contribution to journalArticleAcademicpeer-review

48 Citations (Scopus)


There is still a lack in the molecular comprehension of major depressive disorder (MDD) although this condition affects approximately 10% of the world population. Protein phosphorylation is a posttranslational modification that regulates approximately one-third of the human proteins involved in a range of cellular and biological processes such as cellular signaling. Whereas phosphoproteome studies have been carried out extensively in cancer research, few such investigations have been carried out in studies of psychiatric disorders. Here, we present a comparative phosphoproteome analysis of postmortem dorsolateral prefrontal cortex tissues from 24 MDD patients and 12 control donors. Tissue extracts were analyzed using liquid chromatography mass spectrometry in a data-independent manner (LC-MSE). Our analyses resulted in the identification of 5,195 phosphopeptides, corresponding to 802 non-redundant proteins. Ninety of these proteins showed differential levels of phosphorylation in tissues from MDD subjects compared to controls, being 20 differentially phosphorylated in at least 2 peptides. The majority of these phosphorylated proteins were associated with synaptic transmission and cellular architecture not only pointing out potential biomarker candidates but mainly shedding light to the comprehension of MDD pathobiology.
Original languageUndefined/Unknown
Pages (from-to)657-666
Number of pages10
JournalEuropean Archives of Psychiatry and Clinical Neuroscience
Issue number8
Publication statusPublished - 2012

Cite this